The anti-AD effect of BBR relies on the amelioration of ER stress, which can inhibit the overactivation of GSK3β to prevent the hyperphosphorylation of tau, as well as inhibit eIF2α activation to reduce BACE1 expression (Figure 8). The gene discussed is MAPT; the disease is Alzheimer disease.